What surveillance and preventive measures are recommended for a patient with Cowden syndrome?

Cowden Syndrome: Surveillance and Preventive Measures

Patients with Cowden syndrome require comprehensive, multi-organ cancer surveillance starting in adolescence or early adulthood, with the most critical focus on breast, thyroid, endometrial, renal, and colorectal screening to reduce mortality from the dramatically elevated cancer risks associated with PTEN mutations.

Cancer Risks in Cowden Syndrome

The lifetime cancer burden is substantial, with cumulative risks reaching 85% for breast cancer, 35% for thyroid cancer, 28% for endometrial cancer, 34% for renal cancer, and 9% for colorectal cancer 1. The overall lifetime risk of developing any cancer approaches 89% 1. Women face approximately twice the cancer risk compared to men 1.

Surveillance Protocol by Organ System

Breast Cancer Surveillance (Women)

The most common malignancy in Cowden syndrome requires aggressive screening:

• Breast awareness: Begin at age 18 years 1
• Clinical breast examination: Every 6-12 months starting at age 25 years, or 5-10 years before the youngest family breast cancer diagnosis 1
• Annual mammography AND breast MRI: Begin at age 30-35 years, or individualized based on earliest family onset 1

Risk-reducing mastectomy should be discussed on a case-by-case basis, though no data specifically support this intervention in Cowden syndrome. Counseling must address cancer risk reduction extent, surgical risks, reconstruction options, reproductive desires, and psychosocial/quality-of-life impacts 1.

Thyroid Cancer Surveillance (Both Sexes)

Thyroid cancer represents the predominant cancer risk in childhood, with cases reported as early as age 7 2:

• Annual thyroid ultrasound: Begin at age 18 years, OR 5-10 years before the earliest known family thyroid cancer diagnosis, whichever is earlier 1
• The more recent 2025 guideline suggests starting at age 7 years 3
• Particular attention to thyroid assessment during comprehensive physical examinations 1

Endometrial Cancer Surveillance (Women)

• Patient education regarding endometrial cancer symptoms with emphasis on prompt response 1
• Annual random endometrial biopsies and/or ultrasound: Consider beginning at age 30-35 years 1
• Oophorectomy is NOT indicated for Cowden syndrome alone, though may be warranted for other reasons 1

Renal Cancer Surveillance (Both Sexes)

• Renal ultrasound: Begin at age 40 years, then every 1-2 years thereafter 1

Colorectal Cancer Surveillance (Both Sexes)

Early-onset colorectal cancer occurs in 13% of patients before age 50 1:

• Colonoscopy: Begin at age 35 years, repeat every 5-10 years 1
• More frequent intervals if symptomatic or polyps are identified 1

Dermatologic Surveillance (Both Sexes)

• Annual dermatologic examination: Skin and mouth lesions are common features 1
• Management of dermatologic symptoms as indicated 1

Neurologic Assessment

• Psychomotor assessment in children: Consider at diagnosis, as intellectual disability has been reported with PTEN mutations 1
• Brain MRI: Only indicated with localizing neurologic signs or symptoms 1

General Surveillance Framework

• Annual comprehensive physical examination: Begin at age 18 years, or 5 years before youngest family cancer diagnosis 1
• Education regarding cancer signs and symptoms is essential 1
• Genetic counseling recommended for at-risk relatives 1

Critical Pitfalls to Avoid

1. Do not delay thyroid surveillance: Thyroid cancer can occur as early as age 7, making this the most important pediatric screening consideration 2

2. Do not rely solely on clinical diagnosis: While clinical criteria exist, genetic testing for PTEN mutations should be pursued, as approximately 30-35% of individuals meeting Cowden criteria have identifiable PTEN mutations 3

3. Do not assume negative genetic testing excludes the diagnosis: Cancer surveillance should continue for patients meeting clinical diagnostic criteria even with negative PTEN testing 1

4. Do not overlook family screening: Given autosomal dominant inheritance with high penetrance (≈80%), relatives require genetic counseling and potentially predictive testing 1

5. Recognize ascertainment bias in risk estimates: Published cancer risk estimates may be inflated due to selection bias, as patients were often tested based on having these malignancies 1

Reproductive Counseling

For couples desiring offspring without familial PTEN mutations, discuss options including prenatal diagnosis, preimplantation genetic diagnosis, and assisted reproduction, with comprehensive discussion of risks, benefits, and limitations 1.